Cormac G. Kilty serves as Executive at Nexvet Biopharma plc, where they oversee executive responsibilities. Since joining the company, Cormac G. Kilty has executed 7 insider transactions totaling $57.4K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 31, 2017 involved selling 144,364 shares valued at $970.1K.
Cormac G. Kilty currently holds 10,800 shares of Nexvet Biopharma plc (NVET), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Cormac G. Kilty has been a net buyer of NVET stock. They have purchased $57.4K and sold $0 worth of shares.
Cormac G. Kilty's most recent insider trade was on Jul 31, 2017, when they sold 144,364 shares at $6.72 per share.
Get notified when new Form 4 filings are submitted
| 10,800 |
| $6.72 |
| Discretionary |
| Jul 1, 2017 | NVET | $468 | Option Exercise | 3,600 | $0.13 | Discretionary |
| Jul 1, 2016 | NVET | $468 | Option Exercise | 3,600 | $0.13 | Discretionary |
| Feb 24, 2016 | NVET | $9.5K | Purchase | 3,000 | $3.17 | Discretionary |
| Sep 9, 2015 | NVET | $47.9K | Purchase | 10,000 | $4.79 | Discretionary |
| Jun 30, 2015 | NVET | $468 | Option Exercise | 3,600 | $0.13 | Discretionary |